γ-H2AX: A Novel Prognostic Marker in a Prognosis Prediction Model of Patients with Early Operable Non-Small Cell Lung Cancer

Table 6

Estimation of 3- and 4-year outcome prediction for unlearned data set.

	3-year prediction		4-year prediction
	Learning; data	Validation; data	Learning; data	Validation; data
JR (%)	88.2	72.7	88.2	81.8
No. of patients	75/85	8/11	75/85	9/11
Accuracy (%)	78.7	75	92	88.9
No. of patients	59/75	6/8	69/75	8/9